A detailed history of Morgan Stanley transactions in Infla Rx N.V. stock. As of the latest transaction made, Morgan Stanley holds 668,131 shares of IFRX stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
668,131
Previous 827,831 19.29%
Holding current value
$1.5 Million
Previous $1.44 Million 29.03%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.34 - $1.73 $213,998 - $276,281
-159,700 Reduced 19.29%
668,131 $1.02 Million
Q2 2024

Oct 17, 2024

SELL
$1.18 - $1.74 $177,814 - $262,200
-150,690 Reduced 15.4%
827,831 $1.44 Million
Q2 2024

Aug 14, 2024

SELL
$1.18 - $1.74 $177,814 - $262,200
-150,690 Reduced 15.4%
827,831 $1.44 Million
Q1 2024

Oct 17, 2024

BUY
$1.47 - $2.03 $221,514 - $305,900
150,690 Added 18.2%
978,521 $1.51 Million
Q1 2024

Aug 16, 2024

BUY
$1.47 - $2.03 $81,879 - $113,070
55,700 Added 6.04%
978,521 $1.51 Million
Q1 2024

May 15, 2024

BUY
$1.47 - $2.03 $81,879 - $113,070
55,700 Added 6.04%
978,521 $1.51 Million
Q4 2023

Aug 16, 2024

BUY
$1.25 - $2.75 $118,737 - $261,222
94,990 Added 11.47%
922,821 $1.5 Million
Q4 2023

Feb 13, 2024

BUY
$1.25 - $2.75 $360,876 - $793,927
288,701 Added 45.53%
922,821 $1.5 Million
Q3 2023

Nov 15, 2023

BUY
$2.66 - $4.33 $11,172 - $18,186
4,200 Added 0.67%
634,120 $1.89 Million
Q2 2023

Aug 14, 2023

SELL
$2.05 - $6.1 $30,979 - $92,183
-15,112 Reduced 2.34%
629,920 $2.81 Million
Q1 2023

May 15, 2023

SELL
$1.66 - $3.1 $5,976 - $11,160
-3,600 Reduced 0.56%
645,032 $1.25 Million
Q4 2022

Feb 14, 2023

SELL
$2.11 - $3.25 $98,631 - $151,921
-46,745 Reduced 6.72%
648,632 $2.01 Million
Q3 2022

Nov 14, 2022

SELL
$1.32 - $3.14 $96,828 - $230,334
-73,355 Reduced 9.54%
695,377 $1.84 Million
Q2 2022

Oct 27, 2022

BUY
$0.78 - $1.9 $9,906 - $24,130
12,700 Added 1.68%
768,732 $1.12 Million
Q2 2022

Aug 15, 2022

BUY
$0.78 - $1.9 $9,906 - $24,130
12,700 Added 1.68%
768,732 $1.12 Million
Q1 2022

Oct 27, 2022

SELL
$1.83 - $4.48 $23,241 - $56,896
-12,700 Reduced 1.65%
756,032 $1.38 Million
Q1 2022

May 13, 2022

SELL
$1.83 - $4.48 $215,261 - $526,977
-117,629 Reduced 13.46%
756,032 $1.38 Million
Q4 2021

Feb 14, 2022

BUY
$2.35 - $5.58 $354,112 - $840,827
150,686 Added 20.84%
873,661 $4.16 Million
Q3 2021

Nov 15, 2021

BUY
$2.25 - $3.03 $1.63 Million - $2.19 Million
722,975 New
722,975 $1.87 Million

Others Institutions Holding IFRX

About InflaRx N.V.


  • Ticker IFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,203,800
  • Market Cap $99M
  • Description
  • InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...
More about IFRX
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.